Ervin Sinani

783 total citations
6 papers, 285 citations indexed

About

Ervin Sinani is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Ervin Sinani has authored 6 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Neurology and 1 paper in Molecular Biology. Recurrent topics in Ervin Sinani's work include Neurogenetic and Muscular Disorders Research (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Ervin Sinani is often cited by papers focused on Neurogenetic and Muscular Disorders Research (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Ervin Sinani collaborates with scholars based in United States, Switzerland and Italy. Ervin Sinani's co-authors include Merit Cudkowicz, David Schoenfeld, Alexander Sherman, Melanie Leitner, Neta Zach, Igor Katsovskiy, Jason Walker, Amy M. Shui, Nazem Atassi and James D. Berry and has published in prestigious journals such as Neurology, Neurotherapeutics and Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

In The Last Decade

Ervin Sinani

4 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ervin Sinani United States	4	262	161	62	21	18	6	285
Jason Walker United States	2	199 0.8×	117 0.7×	53 0.9×	15 0.7×	15 0.8×	3	218
Igor Katsovskiy United States	2	199 0.8×	117 0.7×	53 0.9×	15 0.7×	15 0.8×	3	218
Vito Guerra Italy	5	336 1.3×	191 1.2×	44 0.7×	26 1.2×	26 1.4×	5	362
Anne E Visser Netherlands	12	338 1.3×	181 1.1×	95 1.5×	13 0.6×	41 2.3×	14	421
Stefano Zoccolella Italy	7	240 0.9×	128 0.8×	52 0.8×	28 1.3×	30 1.7×	8	279
Daniela Grasso Italy	7	253 1.0×	141 0.9×	63 1.0×	13 0.6×	46 2.6×	10	328
Joachim Wolf Germany	8	169 0.6×	111 0.7×	34 0.5×	30 1.4×	18 1.0×	14	256
Susan Heggie Australia	5	239 0.9×	150 0.9×	45 0.7×	10 0.5×	49 2.7×	7	273
Brenda Thornell United States	5	99 0.4×	61 0.4×	41 0.7×	12 0.6×	7 0.4×	5	168
Beatrice Stubendorff Germany	11	150 0.6×	79 0.5×	74 1.2×	17 0.8×	37 2.1×	20	249

Countries citing papers authored by Ervin Sinani

Since Specialization

Citations

This map shows the geographic impact of Ervin Sinani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ervin Sinani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ervin Sinani more than expected).

Fields of papers citing papers by Ervin Sinani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ervin Sinani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ervin Sinani. The network helps show where Ervin Sinani may publish in the future.

Co-authorship network of co-authors of Ervin Sinani

This figure shows the co-authorship network connecting the top 25 collaborators of Ervin Sinani. A scholar is included among the top collaborators of Ervin Sinani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ervin Sinani. Ervin Sinani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Sherman, Alexander, Jason Walker, Hong Yu, et al.. (2020). NeuroREACH™ Platform for Expanded Access Program (EAP) Trials as the Foundation for Clinical Research of the Future (5463). Neurology. 94(15_supplement).

2.

Sherman, Alexander, James D. Berry, Marc Gotkine, et al.. (2019). PRO-ACE: Global Collaborative Ecosystem in a Post-PRO-ACT Era (P4.6-006). Neurology. 92(15_supplement).

3.

Braun, Nathalie, et al.. (2019). The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 21(1-2). 24–28. 5 indexed citations

4.

Zach, Neta, David L. Ennist, Albert A. Taylor, et al.. (2015). Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?. Neurotherapeutics. 12(2). 417–423. 30 indexed citations

5.

Bedlack, Richard, Timothy E. Vaughan, Paul Wicks, et al.. (2015). How common are ALS plateaus and reversals?. Neurology. 86(9). 808–812. 62 indexed citations

6.

Atassi, Nazem, James D. Berry, Amy M. Shui, et al.. (2014). The PRO-ACT database. Neurology. 83(19). 1719–1725. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact